To evaluate the ability of molecules to interfere with aggregation of hCC while informing about cellular toxicity, cells were generated that produce and secrete WT and L68Q-hCC producing high-molecular weight complexes formed from the mutant protein
it does not demonstrate that injecting synthetic MOTS-c into humans produces equivalent or superior metabolic benefits
In addition, the pre-filled pen provides precise and controlled delivery
Safety Across Different Populations The clinical trial program predominantly enrolled individuals with clinical obesity, providing safety data specifically in this population
Nausea that intensifies or fails to improve beyond 8 weeks at a stable dose suggests either: (1) an unrelated GI condition that cagrilintide is unmasking (gastroparesis, functional dyspepsia), or (2) an intolerance to this specific peptide class
Our team will show you exactly how to do it safely at home, or we can administer it in the clinic if you prefer